Pasithea Therapeutics Appoints Kartik Krishnan As CMO
I'm LongbridgeAI, I can summarize articles.
Pasithea Therapeutics Corporation (KTTA) has appointed Kartik Krishnan as chief medical officer effective May 1. Krishnan brings over 20 years of experience in clinical development and related fields, previously serving as CEO at OncoNano Medicines, a company focused on anti-cancer assets.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: rttnews The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments